Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors (original) (raw)
References
Aoki T, Tashiro K, Miyatake S, Kinashi T, Nakano T, Oda Y, Kikuchi H, Honjo T (1992) Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo. Proc Natl Acad Sci USA 89: 3850 PubMed Google Scholar
Barr E, Carroll J, KAlynych AM, Tripathy S, Kozarsky K, Wilson JM, Leiden JM (1994) Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther 1: 51 PubMed Google Scholar
Bloom HJG, Peckham MJ, Richardson AE, Alexander PA, Payne PM (1973) Glioblastoma mutliforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy. Br J Cancer 27: 253 PubMed Google Scholar
Bloom WH, Carstairs KC, Crompton MR, McKissock W (1960) Autologous glioma transplantation. Lancet 2: 77 PubMed Google Scholar
Bodmer S, Strommer K, Frei K, Siepl C, Tribolet ND, Heid I, Fontana A (1989) Immunosuppression and transforming growth factor-β in glioblastoma. Preferential production of transforming growth factor-β2. J Immunol 143: 3222 PubMed Google Scholar
Bottazzi B, Walter S, Govoni D, Colatto F, Mantovani A (1992) Monocyte chemotactic ctyokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. J Immunol 148: 1280 PubMed Google Scholar
Carr MW, Roth SJ, Luther E, Rose SS, Springer TA (1994) Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 91: 3652 PubMed Google Scholar
Chirgwin JM, Pryzbyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294 PubMed Google Scholar
Cleveland DW, Lopata MA, MacDonald RJ, Cowan NJ, Rutter WJ (1980) Number and evolutionary conservation of α and β tubulin and cytoplasmic β and γ-actin genes using specified cloned cDNA probes. Cell 20: 95 PubMed Google Scholar
Colombo MP, Forni G (1994) Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol Today 15: 48 PubMed Google Scholar
Connor J, Bannerji R, Saito S, Heston W, Fair W, Gilboa E (1993) Regression of bladder tumors in mice treated with interleukin-2 gene-modified tumor cells. J Exp Med 177: 1127 PubMed Google Scholar
Desbaillets I, Tada M, Tribolet Nd, Diserenis AC, Hamou MF, Meir EGV (1994) Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int J Cancer 58: 240 PubMed Google Scholar
Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colongy-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90: 3539 PubMed Google Scholar
Ernst CA, Zhang YJ, Hancock PR, Rutledge BJ, Corless CL, Rollins BJ (1994) Biochemical and biologic characterization of murine monocyte chemoattractant protein-1. Identification of two functional domains. J Immunol 152: 3541 PubMed Google Scholar
Fabry Z, Raine CS, Hart MN (1994) Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol Today 15: 218 PubMed Google Scholar
Gansbacher B, Zier K, Daniels B, Cronin K, Bannerji R, Gilboa E (1990) Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med 172: 1217 PubMed Google Scholar
Golumbek PT, Lazenby AJ, Levitsky HI, Jaffee LM, Karasuyama H, Baker M, Pardoll DM (1991) Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254: 713 PubMed Google Scholar
Grace JT, Perese DM, Metzgar RS, Perese DM, Metzgar RF, Sasabe T, Holdridge B (1961) Tumor autograft response in patients with glioblastoma multiforme. J Neurosurg 18: 159 Google Scholar
Hock H, Dorsch M, Kunzendorf U, Qin Z, Diamantstein T, Blankenstein T (1993) Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, in interferon γ. Proc Natl Acad Sci USA 90: 2774 PubMed Google Scholar
Holladay FP, Choudhuri R, Heitz T, Wood GW (1994) Generation of cytotoxic immune responses during the progression of a rat glioma. J Neurosurg 80: 90 PubMed Google Scholar
Huang AYC, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H (1994) Role of bone marrow-derived cells in presenting MHC class 1-restricted tumor antigens. Science 264: 961 PubMed Google Scholar
Jaeckle KA (1994) Immunotherapy of malignant gliomas. Semin Oncol 21: 249 PubMed Google Scholar
Jiang Y, Beller DI, Frendl G, Graves DT (1992) Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 148: 2423 PubMed Google Scholar
Kobayashi N, Allen N, Clendenon NR, Ko L-W (1980) An improved rat brain-tumor model. J Neurosurg 53: 808 PubMed Google Scholar
Kuppner MC, Hamou M-F, Sawamura Y, Bodmer S, Tribolet Nd (1989) Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor β2. J Neurosurg 71: 211 PubMed Google Scholar
Kuratsu J, Yoshizato K, Yoshimura T, Leonard EJ, Takeshita H, Ushio Y (1993) Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma. J Natl Cancer Inst 85: 1836 PubMed Google Scholar
Kurpad SN, Wilkstrand CJ, Bigner DD (1994) Immunobiology of malignant astrocytomas. Semin Oncol 21: 149 PubMed Google Scholar
Lampson LA (1987) Molecular basis of the immune response to neural antigens. Trends Neurosurg 10: 211 Google Scholar
Leibel SA, Scott CB, Loeffler JS (1994) Contemporary approaches to the treatment of malignant gliomas with radiation therapy. Semin Oncol 21: 198 PubMed Google Scholar
Mahaley MS, Bigner DD, Dudka LF, Wilds PR, Williams DH, Boulden TW, Whitaker JN, Byrium JM (1983) Immunobiology of primary intracranial tumors. Part 7: Active immunization of patients with anaplastic human glioma cells: a pilot study. J Neurosurg 59: 201 PubMed Google Scholar
Mizoguchi H, O'Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC (1992) Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258: 1795 PubMed Google Scholar
Pardoll D (1992) Immunotherapy with cytokine gene-transduced tumor cells: the next wave in gene therapy for cancer. Curr Opin Oncol 4: 1124 PubMed Google Scholar
Porgador A, Bannerji R, Watanabe Y, Feldman M, Gilboa E, Eisenbach L (1993) Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells. J Immunol 150: 1458 PubMed Google Scholar
Rollins BJ, Sunday ME (1991) Suppression of tumor formation in vivo by expression of the JE genen in malignant cells. Mol Cell Biol 11: 3125 PubMed Google Scholar
Rollins BJ, Morrison ED, Stiles CD (1988) Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whore product has cytokine-like properties. Proc Natl Acad Sci USA 85: 3738 PubMed Google Scholar
Rosenthal FM, Zier KS, Gansbacher B (1994) Human tumor vaccines and genetic engineering of tumors with cytokine and histocompatibility genes to enhance immunogenicity. Cur Opin Oncol 6: 611 Google Scholar
Schall TJ (1991) Biology of the RANTES/SIS cytokine family. Cytokines 3: 165 Google Scholar
Tapscott SJ, Miller AD, Olson JM, Berger MS, Groudine M, Spence AM (1994) Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require durg selection. Proc Natl Acad Sci USA 91: 8185 PubMed Google Scholar
Tepper RI, Mule JJ (1994) Experimental and clinical studies of cytokine gene-modified tumor cells. Hum Gene Ther 5: 153 PubMed Google Scholar
Tepper RI, Pattengale PK, Leder P (1989) Murine interleukin-4 displays potent antitumor activity in vivo. Cell 57: 503 PubMed Google Scholar
Townsend SE, Allison JP (1993) Tumor rejection after direct costimulation of CD8+ T cells by B7-1 transfected melanoma cells. Science 259: 368 PubMed Google Scholar
Vieweg J, Rosenthal FM, Bannerji R, Heston WDW, Fair WR, Gansbacher B, Gilboa E (1994) Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines. Cancer Res 54: 1760 PubMed Google Scholar
Watanabe Y, Kuribayashi K, Miyatake S, Nishahara K, Nakayama E, Tahiyama T, Sakata T (1989) Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity. Proc Natl Acad Sci USA 86: 9456 PubMed Google Scholar
Wen PY (1993) Clinical experience with immunotherapy. In: Black PM, Schoene WC, Lampson LA (eds) Astrocytomas. Blackwell, Oxford, p 123 Google Scholar
Yu JS, Wei MX, Chiocca EA, Martuza RL, Tepper RI (1993) Treatment of glioma by engineered interleukin 4-secreting cells. Cancer Res 53: 3125 PubMed Google Scholar